
The authors examine common FDA 483 findings and outline strategies to address and prevent regulatory non-compliance.
Lauren Schoukroun-Barnes, PhD, is associate manager of Regulatory Affairs, Sia/LBG.

The authors examine common FDA 483 findings and outline strategies to address and prevent regulatory non-compliance.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
